PRX-102 Improves Kidney Function in Fabry Patients, Preliminary Phase 3 Data Show
News
Treatment with PRX-102 (pegunigalsidase alfa) can safely and effectively improve kidney function in Fabry disease patients, according to preliminary data from a Phase 3 clinical trial. One year of ... Read more